{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/26/3318133/33090/en/Axsome-Therapeutics-Initiates-FOCUS-3-Phase-3-Trial-of-Solriamfetol-in-Adolescents-with-Attention-Deficit-Hyperactivity-Disorder-ADHD.html", "message": "News view counter 818359 successfully enlarged"}